Evidence map›Paper›PMID 35521350›Full record

ArticleRSC advances2019

Expeditious synthesis and preliminary antimicrobial activity of deflazacort and its precursors.

Anna Esposito, Eliana De Gregorio, Maria De Fenza, Daniele D'Alonzo, Anil Satawani, Annalisa Guaragna

Abstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Frontiers in microbiology · 2026
    Article
  2. Assessing the Potential ofACS pharmacology & translational science · 2024
    Article
  3. Article
  4. Article
  5. PYED-1 Overcomes Colistin Resistance inPathogens (Basel, Switzerland) · 2023
    Article
  6. Journal of medicinal chemistry · 2023
    Article
  7. The Glucocorticoid PYED-1 Disrupts Mature Biofilms ofAntibiotics (Basel, Switzerland) · 2021
    Article
  8. Article
  9. Article
  10. Antibiotics (Basel, Switzerland) · 2020
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anna EspositoDepartment of Chemical Sciences, University of Napoli Federico II Via Cintia 80126 Napoli Italy annalisa.guaragna@unina.it.ORCID https://orcid.org/0000-0003-0139-8316
Eliana De GregorioDepartment of Molecular Medicine and Medical Biotechnologies Via S. Pansini, 5 80131 Napoli Italy.ORCID https://orcid.org/0000-0002-2529-8611
Maria De FenzaDepartment of Chemical Sciences, University of Napoli Federico II Via Cintia 80126 Napoli Italy annalisa.guaragna@unina.it.ORCID https://orcid.org/0000-0002-2856-5615
Daniele D'AlonzoDepartment of Chemical Sciences, University of Napoli Federico II Via Cintia 80126 Napoli Italy annalisa.guaragna@unina.it.ORCID https://orcid.org/0000-0002-2857-8600
Anil SatawaniSymbiotec Pharmalab Pvt Ltd Pithampur Indore India.
Annalisa GuaragnaDepartment of Chemical Sciences, University of Napoli Federico II Via Cintia 80126 Napoli Italy annalisa.guaragna@unina.it.ORCID https://orcid.org/0000-0001-8684-0622

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The synthesis of deflazacort (DFZ) and a preliminary evaluation of its microbial activity against the human pathogens

Identifiers

PMID35521350
PMCPMC9066171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.